STRATA Skin Sciences, Inc.
SSKN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $92,316 | $95,520 | $110,119 | $110,789 |
| - Cash | $7,076 | $5,966 | $6,512 | $7,261 |
| + Debt | $2,877 | $16,353 | $16,397 | $16,439 |
| Enterprise Value | $88,117 | $105,907 | $120,004 | $119,967 |
| Revenue | $6,929 | $7,663 | $6,812 | $9,576 |
| % Growth | -9.6% | 12.5% | -28.9% | – |
| Gross Profit | $4,184 | $4,306 | $3,647 | $5,757 |
| % Margin | 60.4% | 56.2% | 53.5% | 60.1% |
| EBITDA | -$173 | -$693 | -$641 | -$2,838 |
| % Margin | -2.5% | -9% | -9.4% | -29.6% |
| Net Income | -$1,622 | -$2,489 | -$2,432 | -$4,497 |
| % Margin | -23.4% | -32.5% | -35.7% | -47% |
| EPS Diluted | -0.36 | -0.6 | -0.058 | -0.12 |
| % Growth | 40% | -929.2% | 51.4% | – |
| Operating Cash Flow | -$64 | -$1,941 | -$550 | $703 |
| Capital Expenditures | -$1,018 | $61 | -$199 | -$504 |
| Free Cash Flow | -$1,082 | -$1,880 | -$749 | $199 |